José Maria Augé - Concepedia

Author

José Maria Augé

Hospital Clínic de Barcelona

Also Known As

Jose M Auge, Jose M Augé, Jose M. Auge, Jose M. Augé, Jose Maria Auge, José M Augé, José M. Augé, José Maria Augé

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Hospital Clínic de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital de Sant Pau RWTH Aachen University Universitat de Barcelona

About

José Maria Augé is an author at Hospital Clínic de Barcelona specializing in medicine, oncology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	543
2	Health Sciences	2	2	34
3	Public Health	1	1	42
4	Allergy	1	1	11
5	Applied Physiology	1	1	20

José Maria Augé

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases José Miguel Escudero Fernández, José Maria Augé, Xavier Filella, Clinical Chemistry	2011	202
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases Rafael Molina, José Miguel Escudero Fernández, José Maria Augé, Tumor Biology Ca 125Cancer DetectionMedicineRoma AlgorithmHistopathology	2011	172
A randomized comparison ofrepeat stenting with balloon angioplasty in patients with in-stent restenosis Fernándo Alfonso, Javier Zueco, Ángel Cequier, Journal of the American College of Cardiology Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseRandomized Comparison OfrepeatIn-stent Restenosis	2003	139
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE Rafael Molina, José Maria Augé, José Miguel Escudero Fernández, Tumor Biology	2008	122
Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Rafael Molina, José Maria Augé, Xavier Filella, PubMed Translational MedicineUrologyCyfra 21-1Progrp Serum LevelsMedicine	2005	90
Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer Rafael Molina, José Maria Augé, B. Farrús, Clinical Chemistry	2010	88
Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value Rafael Molina, José Maria Augé, José Miguel Escudero Fernández, Tumor Biology	2010	75
CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer Víctor Molina, Laura Visa, Carles Conill, Tumor Biology	2011	53
Pro-Gastrin-Releasing Peptide in Patients with Benign and Malignant Diseases Rafael Molina, José Maria Augé, Julian Alicarte, Tumor Biology	2004	51
CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. Rafael Molina, Xavier Filella, José Maria Augé, PubMed Pretreatment SccCancer ManagementGynecologyPathologyGynecology Oncology	2005	42

Page 1